Rapamycin reduces rejection in heart transplant recipients

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3221-3222

  Radovancevic, B ^a   El Sabrout, R ^a   Thomas, C ^a   Radovancevic, R ^a   Frazier, O H ^a   Van Buren, C ^a  

^a TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SCREENING; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CYCLOSPORINE; DRUG THERAPY, COMBINATION; ETHNIC GROUPS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SIROLIMUS; TEXAS;

EID: 0035671817     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02370-3     Document Type: Article

References (3)

1. Kahan BD for the Rapamune US Study Group: Lancet 356:194, 2000
2. Hong JC, Kahan BD: Transplantation 68:701, 1999
3. MacDonald AS for the Rapamune Global Study Group: Transplantation 71:271, 2001